<DOC>
	<DOCNO>NCT00407836</DOCNO>
	<brief_summary>The hallmark HIV infection AIDS continuous attrition CD4 T cell . One mechanism may account CD4 attrition , autoimmunity CD4 T cell , cause autologous immune cell . Vaccination autoimmune reactive T cell successfully try animal model autoimmune disease try patient Multiple Sclerosis . The purpose present study test hypothesis HIV infection . We vaccinate HIV infect patient specific autoimmune reactivity CD4 present , CD4 reactive T cell . Following , shall study patient find T cell vaccination cause rise CD4 T cell level , whether influence HIV viral load , well HIV CD4 specific immunity .</brief_summary>
	<brief_title>Efficacy Study T Cell Vaccination HIV Infection</brief_title>
	<detailed_description>The study base forty HIV infect patient , receive anti retroviral treatment ( HAART ) , CD4 level 150-350 HIV plasma viral load &lt; 5000 , least 12 month despite continuous anti-retroviral treatment . The patient randomly divide two group , one get T cell vaccination , serve control . The T cell vaccine prepare autologous T cell respond specific proliferation recombinant CD4 , expand vitro IL-2 , fix glutaraldehyde . Each vaccine portion consist 10,000 cell suspended saline give subcutaneously every three month first year trial . The outcome measure CD4 level , specific immunity HIV antigens , immune activation profile HIV plasma viral load , determine sequentially 24 month trial . These outcome measure compare experimental control group , determine mode treatment effective influencing CD4 level additional mode treatment HIV infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . CD4 cell count 150 450/mm3 stable least 12 month , treatment HAART least 6 month . 2 . Positive cell proliferation assay CD4 molecule 3 . Low HIV viral load ( &lt; 400 5000 copies/ml ) least 12 month 4 . No change antiretroviral treatment least 6 month 5 . Signed informed consent 1 . Concomitant immunosuppressive antineoplastic treatment well chronic systemic glucocorticoid therapy . 2 . Pregnancy woman without efficacious contraception . 3 . Clinically relevant liver disease ( AST and/or ALT &gt; 2,5x upper limit normal range , total bilirubin &gt; 3,5 mg/dl ) . 4 . Serum creatinine &gt; 1,8mg/dl creatinine clearance &lt; 30ml/min . 5 . Patients fully understand treatment protocol unable sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>HIV</keyword>
	<keyword>CD4 T cell level</keyword>
	<keyword>CD4 autoimmunity</keyword>
	<keyword>Viral load</keyword>
	<keyword>T cell vaccination</keyword>
	<keyword>HIV Therapeutic Vaccine</keyword>
</DOC>